Details for New Drug Application (NDA): 208616
✉ Email this page to a colleague
The generic ingredient in NEVIRAPINE is nevirapine. There are twenty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the nevirapine profile page.
Summary for 208616
Tradename: | NEVIRAPINE |
Applicant: | Aurobindo Pharma |
Ingredient: | nevirapine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 208616
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Nov 23, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription